Murilo Luz

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

C. Porta, O. Fiala, J. Bellmunt, 2023, Cancer Immunology, Immunotherapy.

Effect of crossover from placebo to darolutamide on overall survival in men with nonmetastatic prostate cancer: Sensitivity analyses from the randomized phase 3 ARAMIS study

T. Tammela, F. Cárcano, T. Sarapohja, 2023, European Journal of Cancer.